Live from ClinicalTrials.gov + Open Targets, fetched 2026-11-12 01:19 UTC. Every row links to its source record.
Postmortem · what the sponsor and named sources said, kept apart from what merely happened at the same time
A Study of Different Programs to Help ALL Patients With Taking Maintenance Medicine at Home
NCT06639958 · Children's Oncology Group · NA · suspended · last registry update 2026-10-05 · Childhood acute lymphoblastic leukemia · Decision brief
No research has been run for this trial yet, so only the registry's own reason and the timeline are shown.
What was said, and by whom
Stated is the sponsor's own words; Reported is a named third party. The category is our label from a fixed list; the quote is the evidence.
| Kind | Quote | Our category | Source |
|---|---|---|---|
| Stated | “All potential pilot phase pts have been enrolled.” | – | Registry record, Children's Oncology Group |
Also happening at the time. Not shown to be a cause.
Registry events on other trials of drugs against PPAT in childhood acute lymphoblastic leukemia within 12 months either side of this trial's last update, live from ClinicalTrials.gov. Nothing here was stated as a reason.
- 2026-07-30Also stopped (terminated): M.D. Anderson Cancer Center, Cyclophosphamide + Cytarabine (NCT03488225)
- 2025-10-22Results posted on the registry: Therapeutic Advances in Childhood Leukemia Consortium, Marqibo (NCT02879643)
- 2025-10-20Results posted on the registry: Dana-Farber Cancer Institute, prednisone + doxorubicin (NCT00136435)
What is not public
- Internal portfolio and board discussions
- Unpublished trial data and interim analyses
- Terms of any partner or licence decision